Biogen | BIIB - Market Capitalization


Biogen reported $28.61B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 391.49B 12.34B Feb/2026
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
ALKERMES USD 5.65B 696M Feb/2026
Amgen USD 201.45B 25.2B Feb/2026
Bayer EUR 27.23B 2.14B Sep/2025
Biogen USD 27.01B 1.19B Feb/2026
BioMarin Pharmaceutical USD 11.99B 575M Feb/2026
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Eli Lilly USD 1.01T 3.37B Feb/2026
Esperion Therapeutics USD 340M 235M Dec/2023
Gilead Sciences USD 183.59B 31.31B Feb/2026
Incyte USD 22.7B 3.31B Feb/2026
Merck USD 300.37B 39.11B Feb/2026
Moderna USD 16.5B 6.41B Feb/2026
Neurocrine Biosciences USD 13.68B 465M Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Pfizer USD 152.89B 11.32B Feb/2026
PTC Therapeutics USD 5.36B 744M Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Sanofi EUR 118.94B 1.6B Feb/2026
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
Ultragenyx Pharmaceutical USD 1.94B 284M Feb/2026
United Therapeutics USD 18.96B 6B Sep/2025
Vertex Pharmaceuticals USD 120.12B 5.09B Feb/2026